Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series.
De Berardis D, Fornaro M, Serroni N, Olivieri L, Marini S, Moschetta FS, Srinivasan V, Assetta M, Valchera A, Salone A, Martinotti G, Onofrj M, Di Giannantonio M. De Berardis D, et al. Among authors: srinivasan v. J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):343-5. doi: 10.1176/appi.neuropsych.12110286. J Neuropsychiatry Clin Neurosci. 2013. PMID: 24247862
Is there a role for agomelatine in the treatment of anxiety disorders?A review of published data.
De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Perna G, Carano A, Piersanti M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: srinivasan v. Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):299-304. doi: 10.1177/039463201302600203. Int J Immunopathol Pharmacol. 2013. PMID: 23755745 Free article. Review.
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: srinivasan v. Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111. Int J Mol Sci. 2015. PMID: 25569089 Free PMC article. Review.
The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review.
De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: srinivasan v. CNS Neurol Disord Drug Targets. 2013 Mar;12(2):252-64. doi: 10.2174/1871527311312020012. CNS Neurol Disord Drug Targets. 2013. PMID: 23469841 Review.
Metabolic syndrome, its pathophysiology and the role of melatonin.
Srinivasan V, Ohta Y, Espino J, Pariente JA, Rodriguez AB, Mohamed M, Zakaria R. Srinivasan V, et al. Recent Pat Endocr Metab Immune Drug Discov. 2013 Jan;7(1):11-25. Recent Pat Endocr Metab Immune Drug Discov. 2013. PMID: 22946959 Review.
Multicenter analysis of the incidence of in-stent stenosis following the deployment of flow-redirection endoluminal device in the treatment of intracranial aneurysms.
Gajjar AA, Sioutas GS, Custozzo A, Salem MM, Field NC, Shekhtman O, Davis P, Prabhala T, Jankowitz BT, Dalfino JC, Boulos AS, Burkhardt JK, Paul AR, Srinivasan VM. Gajjar AA, et al. Among authors: srinivasan vm. Interv Neuroradiol. 2025 Jan 13:15910199241304855. doi: 10.1177/15910199241304855. Online ahead of print. Interv Neuroradiol. 2025. PMID: 39801312 Free PMC article.
1,621 results